Cost–consequence analysis of 18F-fluciclovine for the staging of recurrent prostate cancer
2020
Background: Current detection methodologies are often unable to identify the location and extent of recurrent prostate cancer (PCa) leading potentially to ‘futile’ local therapies in the presence o...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
23
References
2
Citations
NaN
KQI